Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Sunday, April 22, 2018 · 443,391,360 Articles · 3+ Million Readers

Global Non-Small Cell Lung Cancer (NSCLC) Market Analysis & Forecast 2017-2025

PUNE, INDIA, April 6, 2018 /EINPresswire.com/ -- WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Non-Small Cell Lung Cancer (NSCLC) - Dynamic Market Forecast to 2025”

Non-Small Cell Lung Cancer (NSCLC)

Overview

The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape. The Forecast Update is designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand how these events will impact the market forecast.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3054184-non-small-cell-lung-cancer-nsclc-dynamic-market-forecast-to-2025

 

Table of Contents

Table of Contents (PowerPoint Deck)

1 Dynamic Market Forecast Overview

1.1 Related Reports

1.2 Upcoming Related Reports

2 Executive Summary

2.1 Key Events in Update

2.2 Updates to Treatment Algorithms

2.3 Clinical Trial Landscape Updates

2.4 Pipeline Landscape Updates

2.5 Market Insight on Key Events

3 Event 1: Market Dynamics Shift in Frontline NSCLC

3.1 Key Updates to the Frontline Setting - Elderly Patients

3.2 Merck & Co., Keytruda (pembrolizumab)

3.3 AstraZeneca, Imfinzi (durvalumab) + tremelimumab

3.4 Pfizer and Merck KGaA , Bavencio (avelumab)

3.5 Roche, Tecentriq (atezolizumab)

3.6 Novartis, Tafinlar (dabrafenib) + Mekinist (trametinib)

3.7 Additional Clinical Trial Updates- Frontline Setting

3.8 Summary/Trends

3.9 Sources

4 Event 2: Weak Competition in the EGFRm+ Segment Creates Opportunity for Tagrisso

4.1 Key Updates to the EGFRm+ Segment

4.2 AstraZeneca, Tagrisso (osimertinib)

4.3 Pfizer, dacomitinib

4.4 Additional Clinical Trial Updates- EGFRm+ Setting

4.5 Summary/Trends

4.6 Sources

Non-Small Cell Lung Cancer (NSCLC) Industry Major Outlook

Key events covered in the Dynamic Market Forecast include - 
- Regulatory filings 
- Approval decisions 
- Pricing changes 
- Patent litigation 
- Clinical trial data announcements 
- Clinical trial failures 
- Clinical trial timeline updates

- Overview of updates to the forecast model based on anticipated future impact of events 
- Forward-looking events calendar listing expected key updates to the NSCLC competitive space in the next quarter

Non-Small Cell Lung Cancer (NSCLC) - Competitive Analysis

Key players are making innovative developments in Non-Small Cell Lung Cancer (NSCLC) industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3054184-non-small-cell-lung-cancer-nsclc-dynamic-market-forecast-to-2025

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire